Sequence-dependent strategies for the optimisation of combinations of PI3K pathway inhibitors and classical anticancer agents


Year:

Session type:

Marco Mazzoletti, Massimo Broggini

Mario Negri Institute, Milan, Italy

Abstract

Background

PI3K pathway acts as a key cellular regulator through the activation of